RajatThawaniMD

Oncology • Chicago, IL

Thoracic Cancer, Clinical Pharmacology

Thoracic Oncologist at the University of Chicago Medicine

Join to view full profile

Dr. Thawani is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Thawani's full profile

Already have an account?

Office
5841 S Maryland Ave
Chicago, IL 60637
Phone+1 855-702-8222

Summary

Thoracic oncologist interested in patient care, drug development and translational oncology

Education & Training

Oregon Health & Science University (OHSU Health)Fellowship, Hematology and Medical Oncology, 2020 - 2023
Maimonides Medical CenterResidency, Internal Medicine, 2017 - 2020
Delhi University College of Medical SciencesClass of 2014

Certifications & Licensure

IL State Medical License 2023 - 2026
OR State Medical License 2020 - 2025
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Fellow Teaching Award OHSU Internal Medicine Residency, 2022
Fellow Research Award OHSU Internal Medicine, 2022
Abstract Achievement Award American Society of Hematology, 2021
Resident Research Award Maimonides Medical Center, 2020
Resident Achievement Award Maimonides Medical Center, 2019
Resident Research Award 19 Maimonides Medical Center, 2019
Quality, Patient Safety and Advocacy Award New York American College of Physicians, 2019
Join now to see all

Clinical Trials

Ramucirumab Plus Pembrolizumab vs Usual Care for Treatment of Stage IV or Recurrent Non-Small Cell Lung Cancer Following Immunotherapy, Pragmatica-Lung Study Start of enrollment: 2023 Mar 14
Recruiting
Phase 3

Publications & Presentations

PubMed

DARES: A Phase II Trial of Durvalumab and Ablative Radiation in Extensive-Stage Small Cell Lung Cancer.
Christine M Bestvina, Jared H L Hara, Theodore Karrison, Benjamen Bowar, Janet Chin
Clinical Lung Cancer. 2024-12-01
Trends in complexity of single-agent and combination therapies for solid tumor cancers approved by the US Food and Drug Administration.
Emerson Y Chen, Manoj Rai, Yash Tadikonda, Preeyam Roy, Dakota W Nollner
The Oncologist. 2024-11-15
Time to rethink platinum choices in the era of immunotherapy in lung cancer.
E Harris, N F Taflin, A Chitkara, M Tagliamento, C M Bestvina
Annals of Oncology. 2024-10-11

Press Mentions

Foreign PracticeNovember 17th, 2014
New Imaging Technology May Help Predict Aggressiveness of Lung CancerOctober 7th, 2018
A New Generation of Physicians Matures into Patient Safety LeadershipNovember 26th, 2020
Join now to see all

Grant Support

ROS1 in chemopreventionNL Tartar Trust2022–Present
Strategies to bypass intrinsic resistance in ROS1 rearranged non-small cell lung cancerMedical Research Foundation of Oregon2022–2023
Resident Research grantMaimonides Research and Development Foundation2017–2018
CIR Wellness GrantCommittee of Interns and ResidentsPresent

Committees

Member, Global Policy and Partnerships Committee 2024 - Present

Professional Memberships

American Society of Clinical Oncology - ASCO
Member
American Association for Cancer Research - AACR
Member
Society for Immunotherapy of Cancer
Member
International Association for the Study of Lung Cancer
Member

Other Languages

Hindi